GH1 and diabetes mellitus: A review of data from large-scale registry studies of patients receiving GH replacement therapy concluded that the incidence of diabetes mellitus may only be slightly increased in patients with pre-existing risk factors for diabetes mellitus, rather than due to changes resulting from rhGH therapy [19].